Skip to content

Safety of stem cells in treatmemt of retinal diseases.

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-503573-38-00
Enrollment
10
Registered
2026-04-28
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retinal degenerative diseases

Interventions

None listed

Sponsors

Bioinova a.s.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Outcome results

None listed

Source: EU CTIS · Data processed: Apr 29, 2026